Lääkemarkkinat kansantaloudessa ja lääkkeiden kysynnän kehitysnäkymät

Reijo Mankinen

No 1009, Discussion Papers from The Research Institute of the Finnish Economy

Abstract: Population aging is expected to lead to strong growth in healthcare expenditure as a share of GDP. So far, costs have increased only modestly in international comparison. Over the next ten years, the baby boomers will reach ages (61-70 years) where per capita pharmaceuticals consumption is greatest. Thus, healthcare expenditure is expected to expand rapidly, reflecting this higher demand for pharmaceuticals. The share of domestic production in the Finnish pharmaceutical market has declined considerably along with keener competition in the market. On the other hand, higher competition has kept cost increases at subdued levels.

Keywords: The pharmaceutical market; the relationship between inputs and production in the pharmaceutical industry; imported production inputs; prospects for pharmaceuticals demand (search for similar items in EconPapers)
Pages: 30 pages
Date: 2006
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.etla.fi/wp-content/uploads/2012/09/dp1009.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:rif:dpaper:1009

Ordering information: This working paper can be ordered from
https://www.etla.fi/en/publications/dp1009-en/

The price is 10€.

Access Statistics for this paper

More papers in Discussion Papers from The Research Institute of the Finnish Economy Contact information at EDIRC.
Bibliographic data for series maintained by Kaija Hyvönen-Rajecki ().